View Item 

Show simple item record

Geographic variation in heart failure trials: time for scepticism?
dc.contributor.authorPitt, Bertramen_US
dc.contributor.authorGheorghiade, Mihaien_US
dc.date.accessioned2014-07-03T14:41:30Z
dc.date.availableWITHHELD_12_MONTHSen_US
dc.date.available2014-07-03T14:41:30Z
dc.date.issued2014-06en_US
dc.identifier.citationPitt, Bertram; Gheorghiade, Mihai (2014). "Geographic variation in heart failure trials: time for scepticism?." European Journal of Heart Failure 16(6): 601-602.en_US
dc.identifier.issn1388-9842en_US
dc.identifier.issn1879-0844en_US
dc.identifier.urihttps://hdl.handle.net/2027.42/107539
dc.publisherJohn Wiley & Sons, Ltden_US
dc.titleGeographic variation in heart failure trials: time for scepticism?en_US
dc.typeArticleen_US
dc.rights.robotsIndexNoFollowen_US
dc.subject.hlbsecondlevelCardiovascular Medicineen_US
dc.subject.hlbtoplevelHealth Sciencesen_US
dc.description.peerreviewedPeer Revieweden_US
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/107539/1/ejhf112.pdf
dc.identifier.doi10.1002/ejhf.112en_US
dc.identifier.sourceEuropean Journal of Heart Failureen_US
dc.identifier.citedreferencePitt B, Pfeffer MA, Assmann SF, Boineau R, Anand IS, Claggett B, Clausell N, Desai AS, Diaz R, Fleg JL, Gordeev I, Harty B, Heitner JF, Kenwood CT, Lewis EF, O'Meara E, Probstfield JL, Shaburishvili T, Shah SJ, Solomon SD, Sweitzer NK, Yang S, McKinlay SM, TOPCAT Investigators. Spironolactone for heart failure with preserved ejection fraction. N Eng J Med 2014; 370: 1383 – 1392.en_US
dc.identifier.citedreferenceO'Connor CM, Stough WG, Gallup DS, Hasselblad V, Gheorghiade M. Demographics, clinical characteristics, and outcomes of patients hospitalized for decompensated heart failure: Observations from the Impact‐HF Registry. J Card Fail 2005; 11: 200 – 205.en_US
dc.identifier.citedreferenceBlair JE, Zannad F, Konstam MA, Cook T, Traver B, Burnett JC, Grinfeld L, Krasa H, Maggioni AP, Orlandi C, Swedberg K, Udelson JE, Zimmer C, Gheorghiade M, EVEREST Investigators. Continental differences in clinical characteristics, management, and outcomes in patients hospitalized with worsening heart failure. Results from the Everest (efficacy of vasopressin antagonism in he3art failure: outcome study with tolvaptan) program. JACC 2008; 52: 1640 – 1648.en_US
dc.identifier.citedreferenceButler J, Subacius H, Vaduganthan M, Fonarow GC, Ambrosy AP, Konstam MA, Maggioni A, Mentz RJ, Swedberg K, Zannad F, Gheorghiade M, EVEREST Investigators. Relationship between clinical trial site enrollment with participant characteristics, protocol completion, and outcomes: insights from the Everest (efficacy of vasopressin antagonism in heart failure: outcome study with tolvaptan) trial. JACC 2013; 61: 571 – 579.en_US
dc.identifier.citedreferenceGheorghiade M, Vaduganathan M, Greene SJ, Mentz RJ, Adams KF Jr, Anker SD, Arnold M, Baschiera F, Cleland JG, Cotter G, Fonarow GC, Giordano C, Metra M, Misselwitz F, Muhlhofer E, Nodari S, Frank Peacock W, Pieske BM, Sabbah HN, Sato N, Shah MR, Stockbridge NL, Teerlink, van Veldhuisen DJ, Zalewski A, Zannad F, Butler J. Site selection in global clinical trials in patients hospitalized for heart failure. Perceived problems and potential solutions. Heart Fail Rev 2014; 19: 135 – 152en_US
dc.identifier.citedreferenceMentz RJ, Kaski JC, Dan GA, Goldstein S, Stockbridge N, Alonso‐Garcia A, Ruilope LM, Martinez FA, Zannad F, Pitt B, Fiuzat M, O'Connor CM. Implications of geographic variation on clinical outcomes of cardiovascular trials. Am Heart J 2012; 164: 303 – 312.en_US
dc.identifier.citedreferencePitt B, Zannad F, Gheorghiade M, Martinez F, Love TE, Daniel C, Ahmed A. Transatlantic similarities and differences in major natural history endpoints of heart failure after acute myocardial infarction: a propensity‐matched study of the EPHESUS trial. Int J Cardiol 2010; 143: 309 – 316.en_US
dc.identifier.citedreferenceEapen ZJ, Reed SD, Li Y, Kociol RD, Armstrong PW, Starling RC, McMurray JJ, Massie BM, Swedberg K, Ezekowitz JA, Fonarow GC, Teerlink JR, Metra M, Whellan DJ, O'Connor CM, Califf RM, Hernandez AF. Do countries or hospitals with longer hospital stays for acute heart failure have lower readmissions rates? Findings from ASCEND‐HF. Circ Heart Fail 2013; 6: 727 – 732.en_US
dc.identifier.citedreferenceMentz RJ, Cotter G, Cleland J, Stevens SR, Chiswell K, Davidson BA, Teerlink JR, Metra M, Voors AA, Grinfeld L, Ruda M, Mareev V, Lotan C, Bloomfield DM, Fiuzat M, Givertz MM, Ponikowski P, Massie BM, O'Connor CM. International differences in clinical characteristics, management, and outcomes in acute heart failure patients: better short‐term outcomes in patients enrolled in eastern Europe and Russia in the PROTECT Trial. Eur J. Heart Fail; 2014; 6: 614 – 624.en_US
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Name:
ejhf112.pdf
Size:
52.36KB
Format:
PDF
View/Open

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.